Sort   by:  
 Page size 
ProteomicsOvarian Cancer Biomarkers - DIGE Spot identification
Identification of markers for the diagnosis of early stage ovarian cancer
ORGANISM(S): Homo sapiens (Human) 
2020-08-26 | PXD018417 | Pride
Lc-ms 2d gel Human 
ProteomicsFormalin-fixed Human Ovarian Cancer Tryptic Peptide LC-MS/MS
LC-MS/MS (LTQ-Orbitrap, CID) data sets of 31 human ovarian cancer samples (FFPE). Sample material obtained by laser microdissection of cores from tissue microarray. Preparation matching MALDI imaging protocol (as described in Gustafsson, J Proteomics 2012).
ORGANISM(S): Homo sapiens (Human) 
2013-02-28 | PXD000079 | Pride
Ovarian cancer Ffpe Maldi imaging Formalin Human Lc-ms/ms 
UnknownHigh levels of genomic aberrations in serous ovarian cancers are associated with better survival.
Not available
S-EPMC3553118 | biostudies-literature
UnknownSmall-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer.
Not available
S-EPMC10711013 | biostudies-literature
UnknownMethylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma.
Not available
S-EPMC6162272 | biostudies-literature
UnknownTiming of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer.
Not available
S-EPMC11258338 | biostudies-literature
UnknownPaclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer.
Not available
S-EPMC4015028 | biostudies-literature
UnknownBRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
Not available
S-EPMC11299415 | biostudies-literature
UnknownFine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Not available
S-EPMC4321445 | biostudies-literature
UnknownMyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Not available
S-EPMC5870793 | biostudies-literature
Sort   by:  
 Page size